It's the second year in a row that Lilly has used the Oscars as a platform to drive home a message about GLP-1-based obesity ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
Though the Healthy Skepticism ads don’t specifically call out compounded GLP-1s, Lilly said in a statement to MM+M that ...
Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...
Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...
Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...
It's hard to argue with the kinds of results Eli Lilly ( LLY 1.71%) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
Recent health news highlights include U.S. agency participation in a WHO meeting despite a planned exit, the UK's approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback